November 27, 2017By CenterWatch StaffNightingale named One of the Most Innovative Biotech SMEs in Europe
November 27, 2017By CenterWatch StaffCambridge Epigenetix appoints Professor Mark Dawson as Scientific Advisor
November 20, 2017By CenterWatch StaffTESARO announces EC approval of ZEJULA for recurrent ovarian cancer
November 8, 2017By CenterWatch StaffU.K. pharma view on gov’t response to the Accelerated Access Review
September 27, 2017By CenterWatch StaffVivet’ Vtx 801 for Wilson’s receives European/U.S. Orphan designation
July 21, 2017By CenterWatch StaffScience Exchange R&D outsourcing platform to receive privacy certification
July 14, 2017By CenterWatch StaffVertex gains reimbursement agreement in Italy for cystic fibrosis drug Orkambi